Shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN - Get Free Report) have been given an average rating of "Hold" by the four research firms that are currently covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $18.54.
Several brokerages recently weighed in on CCRN. Benchmark cut shares of Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, December 4th. William Blair cut shares of Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a report on Wednesday, December 4th. Truist Financial boosted their price objective on shares of Cross Country Healthcare from $15.00 to $18.61 and gave the company a "hold" rating in a research note on Thursday, December 5th. Barrington Research reaffirmed a "market perform" rating on shares of Cross Country Healthcare in a report on Tuesday, December 10th. Finally, StockNews.com assumed coverage on shares of Cross Country Healthcare in a research report on Tuesday, January 7th. They issued a "hold" rating for the company.
Check Out Our Latest Report on Cross Country Healthcare
Institutional Trading of Cross Country Healthcare
Several hedge funds have recently modified their holdings of CCRN. Truvestments Capital LLC acquired a new stake in shares of Cross Country Healthcare in the 3rd quarter worth approximately $39,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Cross Country Healthcare in the third quarter valued at $49,000. Point72 DIFC Ltd purchased a new position in shares of Cross Country Healthcare in the third quarter valued at $52,000. Gladius Capital Management LP increased its position in shares of Cross Country Healthcare by 83.4% in the third quarter. Gladius Capital Management LP now owns 3,985 shares of the business services provider's stock valued at $54,000 after buying an additional 1,812 shares in the last quarter. Finally, US Bancorp DE raised its stake in shares of Cross Country Healthcare by 10,909.3% during the 3rd quarter. US Bancorp DE now owns 4,734 shares of the business services provider's stock worth $64,000 after buying an additional 4,691 shares during the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.
Cross Country Healthcare Trading Down 0.2 %
NASDAQ CCRN traded down $0.04 during trading on Friday, reaching $18.20. The company's stock had a trading volume of 458,263 shares, compared to its average volume of 639,594. The firm has a 50 day moving average price of $14.86 and a 200 day moving average price of $14.34. The firm has a market capitalization of $599.09 million, a price-to-earnings ratio of -363.93, a price-to-earnings-growth ratio of 3.39 and a beta of 0.46. Cross Country Healthcare has a 12 month low of $9.58 and a 12 month high of $23.63.
About Cross Country Healthcare
(
Get Free ReportCross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Featured Stories
Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.